Yale Jen
Stock Analyst at Laidlaw & Co.
(0.29)
# 4,370
Out of 5,116 analysts
15
Total ratings
13.33%
Success rate
-13.12%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTN Palatin Technologies | Initiates: Buy | $60 | $16.00 | +275.00% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.73 | +792.86% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $7.50 | +193.33% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $1.15 | +334.78% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $49.11 | +113.81% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $7.65 | +148.37% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.63 | +1,482.78% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $145.31 | -66.97% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $2.00 | +23,650.00% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $2.00 | +11,150.00% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.00 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.39 | +2,495.38% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.40 | - | 1 | Aug 15, 2023 |
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $16.00
Upside: +275.00%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.73
Upside: +792.86%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $7.50
Upside: +193.33%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $1.15
Upside: +334.78%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $49.11
Upside: +113.81%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $7.65
Upside: +148.37%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.63
Upside: +1,482.78%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $145.31
Upside: -66.97%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $2.00
Upside: +23,650.00%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $2.00
Upside: +11,150.00%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.00
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.39
Upside: +2,495.38%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.40
Upside: -